Contact
Sitemap
About us
Health
Products
Community
Careers
Media
Current Releases
Archive
Tip a friend
Print
Press release
,
09.09.2009
Four studies published in The Lancet show roflumilast (Daxas), a new oral approach to COPD, improves lung function and reduces exacerbations
Lancet Canadian Press Release
Select language : EN-FR
English
Francais
© Nycomed, 2010
Nycomed Canada Inc., 435 North Service Rd. West, 1st floor Oakville, Ontario L6M 4X8